Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif.


Journal

Protein science : a publication of the Protein Society
ISSN: 1469-896X
Titre abrégé: Protein Sci
Pays: United States
ID NLM: 9211750

Informations de publication

Date de publication:
05 2019
Historique:
received: 03 01 2019
revised: 13 02 2019
accepted: 19 02 2019
pubmed: 23 2 2019
medline: 31 3 2020
entrez: 23 2 2019
Statut: ppublish

Résumé

We previously described structural and functional characterization of the first ubiquitin variant (UbV), UbV.v27.1, engineered by phage display to bind with high affinity to a specific ubiquitin interacting motif (UIM). We identified two substitutions relative to ubiquitin (Gly10Val/His68Tyr) that were critical for enhancing binding affinity but could only rationalize the mechanism of action of the Tyr68 substitution. Here, we extend our characterization and uncover the mechanism by which the Val10 substitution enhances binding affinity. We show that Val10 in UbV.v27.1 drives UbV dimerization through an intermolecular β-strand exchange. Dimerization serves to increase the contact surface between the UIM and UbV and also affords direct contacts between two UIMs through an overall 2:2 binding stoichiometry. Our identification of the role of Val10 in UbV dimerization suggests a general means for the development of dimeric UbVs with improved affinity and specificity relative to their monomeric UbV counterparts. Statement: Previously, we used phage display to engineer a UbV that bound tightly and specifically to a UIM. Here, we discovered that tight binding is partly due to the dimerization of the UbV, which increases the contact surface between the UbV and UIM. We show that UbV dimerization is dependent on the Gly10Val substitution, and posit that dimerization may provide a general means for engineering UbVs with improved binding properties.

Identifiants

pubmed: 30793400
doi: 10.1002/pro.3593
pmc: PMC6459996
doi:

Substances chimiques

Ubiquitin 0
Valine HG18B9YRS7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

848-856

Subventions

Organisme : CIHR
ID : FDN143277
Pays : Canada
Organisme : CIHR
ID : MOP-136956
Pays : Canada

Informations de copyright

© 2019 The Protein Society.

Références

Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50
pubmed: 16552146
Mol Biosyst. 2006 Jan;2(1):49-57
pubmed: 16880922
EMBO J. 2003 Sep 15;22(18):4597-606
pubmed: 12970172
Biochemistry. 1991 Nov 12;30(45):10832-8
pubmed: 1932005
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Science. 2002 May 17;296(5571):1308-13
pubmed: 11964443
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Structure. 2019 Apr 2;27(4):590-605.e5
pubmed: 30713027
Protein Sci. 2017 May;26(5):1060-1069
pubmed: 28276594
Science. 2013 Feb 1;339(6119):590-5
pubmed: 23287719
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Mol Cell. 2017 Oct 19;68(2):456-470.e10
pubmed: 29053960
Structure. 1996 Sep 15;4(9):1077-92
pubmed: 8805593

Auteurs

Noah Manczyk (N)

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

Gianluca Veggiani (G)

Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, M5S 3E1 Toronto, Ontario, Canada.

Gerald D Gish (GD)

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.

Bradley P Yates (BP)

Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, M5S 3E1 Toronto, Ontario, Canada.

Andreas Ernst (A)

Institute of Biochemistry II, Goethe University, Frankfurt am Main 60590, Germany.

Sachdev S Sidhu (SS)

Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, M5S 3E1 Toronto, Ontario, Canada.

Frank Sicheri (F)

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH